These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32155673)

  • 1. A novel metformin derivative showed improvement of lipid metabolism in obese rats with type 2 diabetes.
    Chen D; Jia D; Wu X; Shi K; Ren C; Dou Y; Guo M; Wang J; Ma M; Wu Z; Shi HY; Li W; Feng Y; Wu F
    Clin Exp Pharmacol Physiol; 2020 Aug; 47(8):1382-1392. PubMed ID: 32155673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel triazine ring compound (MD568) exerts in vivo and in vitro effects on lipid metabolism.
    Jia D; Li Z; Gao Y; Feng Y; Li W
    Biomed Pharmacother; 2018 Jul; 103():790-799. PubMed ID: 29684858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel berberine-metformin hybrid compound exerts therapeutic effects on obese type 2 diabetic rats.
    Jia D; Li ZW; Zhou X; Gao Y; Feng Y; Ma M; Wu Z; Li W
    Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):533-544. PubMed ID: 30883863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-diabetic effects of mildronate alone or in combination with metformin in obese Zucker rats.
    Liepinsh E; Skapare E; Svalbe B; Makrecka M; Cirule H; Dambrova M
    Eur J Pharmacol; 2011 May; 658(2-3):277-83. PubMed ID: 21371472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yam Gruel alone and in combination with metformin regulates hepatic lipid metabolism disorders in a diabetic rat model by activating the AMPK/ACC/CPT-1 pathway.
    Dai Y; Qiu C; Zhang D; Li M; Liu W
    Lipids Health Dis; 2024 Jan; 23(1):28. PubMed ID: 38273354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes.
    Tiikkainen M; Häkkinen AM; Korsheninnikova E; Nyman T; Mäkimattila S; Yki-Järvinen H
    Diabetes; 2004 Aug; 53(8):2169-76. PubMed ID: 15277403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic and proteomic analysis of potential therapeutic target genes in the liver of metformin‑treated Sprague‑Dawley rats with type 2 diabetes mellitus.
    Chen Y; Wu Y; Yang Y; Xu Z; Tong J; Li Z; Zhou X; Li C
    Int J Mol Med; 2018 Jun; 41(6):3327-3341. PubMed ID: 29512687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of KY-903, a Novel Tetrazole-Based Peroxisome Proliferator-Activated Receptor γ Modulator, in Male Diabetic Mice and Female Ovariectomized Rats.
    Ito Y; Yamamoto M; Furukawa S; Fukui M; Morishita K; Kitao T; Shirahase H
    Biol Pharm Bull; 2021; 44(5):659-668. PubMed ID: 33952822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular effects of ER alpha- and beta-selective agonists on regulation of energy homeostasis in obese female Wistar rats.
    Weigt C; Hertrampf T; Kluxen FM; Flenker U; Hülsemann F; Fritzemeier KH; Diel P
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):147-58. PubMed ID: 23871901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus.
    Bajaj M; Suraamornkul S; Hardies LJ; Glass L; Musi N; DeFronzo RA
    Diabetologia; 2007 Aug; 50(8):1723-31. PubMed ID: 17520238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
    Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective effect of 1alpha, 25-dihydroxyvitamin d3 and metformin on liver in type 2 diabetic rats.
    Elattar S; Estaphan S; Mohamed EA; Elzainy A; Naguib M
    J Steroid Biochem Mol Biol; 2017 Oct; 173():235-244. PubMed ID: 27876536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.
    Murakami K; Tobe K; Ide T; Mochizuki T; Ohashi M; Akanuma Y; Yazaki Y; Kadowaki T
    Diabetes; 1998 Dec; 47(12):1841-7. PubMed ID: 9836514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LT175 is a novel PPARα/γ ligand with potent insulin-sensitizing effects and reduced adipogenic properties.
    Gilardi F; Giudici M; Mitro N; Maschi O; Guerrini U; Rando G; Maggi A; Cermenati G; Laghezza A; Loiodice F; Pochetti G; Lavecchia A; Caruso D; De Fabiani E; Bamberg K; Crestani M
    J Biol Chem; 2014 Mar; 289(10):6908-6920. PubMed ID: 24451380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agriophyllum oligosaccharides ameliorate hepatic injury in type 2 diabetic db/db mice targeting INS-R/IRS-2/PI3K/AKT/PPAR-γ/Glut4 signal pathway.
    Bao S; Wu YL; Wang X; Han S; Cho S; Ao W; Nan JX
    J Ethnopharmacol; 2020 Jul; 257():112863. PubMed ID: 32302715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.
    Cusi K; Consoli A; DeFronzo RA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4059-67. PubMed ID: 8923861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
    Teranishi T; Ohara T; Maeda K; Zenibayashi M; Kouyama K; Hirota Y; Kawamitsu H; Fujii M; Sugimura K; Kasuga M
    Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the mode-of-action of Cassia auriculata via in silico and in vivo studies towards validating it as a long term therapy for type II diabetes.
    Mohd Fauzi F; John CM; Karunanidhi A; Mussa HY; Ramasamy R; Adam A; Bender A
    J Ethnopharmacol; 2017 Feb; 197():61-72. PubMed ID: 27452659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan reduces plasma adipocytokines and lipid accumulation in liver and adipose tissues and ameliorates insulin resistance in diabetic rats.
    Hsieh YL; Yao HT; Cheng RS; Chiang MT
    J Med Food; 2012 May; 15(5):453-60. PubMed ID: 22439875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.